Showing results (691-700 of 739) with videos related to

Sort By:
Pageof 74
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2025
Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trialT Powles, S Tagawa, C Vulsteke, et al.
ESMO Open|August 30, 2024
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II studyA Rodriguez-Vida, B P Valderrama, D Castellano, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2022
The amino acid sensor GCN2 controls red blood cell clearance and iron metabolism through regulation of liver macrophagesPhoenix Toboz, Mehdi Amiri, Negar Tabatabaei, et al.
The Journal of Clinical Investigation|July 4, 2012
Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolismAlanna Strong, Qiurong Ding, Andrew C Edmondson, et al.
Journal of Translational Medicine|March 5, 2024
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockadeShuming Chen, Tracee L McMiller, Abha Soni, et al.
BMC Cancer|May 25, 2021
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)P Grivas, Y Loriot, R Morales-Barrera, et al.
Journal of the American College of Cardiology|April 15, 2026
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes MellitusFan Bu, Ruopeng Wu, Anna Ostropolets, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2017
A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN)J Bellmunt, J M Kerst, F Vázquez, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|November 17, 2022
Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countriesF Lucy Wright, Kate Cheema, Raph Goldacre, et al.
Annals of Surgical Oncology|May 22, 2019
RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity ScoreA Arjona-Sanchez, L Rodriguez-Ortiz, D Baratti, et al.
Pageof 74